Aldatu Biosciences advances the development of innovative diagnostic tools that drive our collective response to global health emergencies. Aldatu’s proprietary PANDAA technology is a qPCR-enabling platform that overcomes long-standing diagnostic challenges to enhance the quality and affordability of high-throughput infectious disease diagnostics and improve patient access to diagnostics in resource-limited countries. Our PANDAA qDx™ SARS-CoV-2 assay is being implemented in numerous clinical labs and we have established Aldatu Diagnostics, a clinical lab dedicated to supporting our community’s needs for COVID-19 testing using Aldatu Biosciences’ PANDAA technology.
Company Details
- Employees
- 8
- Founded
- 2014
- Address
- 313 Pleasant Street, 1st Floor
- ch****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aldatubio.com
- HQ
- Watertown, Massachusetts
Aldatu Biosciences Questions
Aldatu Biosciences's website is aldatubio.com
Aldatu Biosciences's LinkedIn profile is https://www.linkedin.com/company/aldatu-biosciences
Aldatu Biosciences has
8 employees.
View email and phone details for 8
employees at Aldatu Biosciences.
Aldatu Biosciences's industry is
Biotechnology Research
Aldatu Biosciences's top competitors are
Casma Therapeutics,
Berkeley Angel Network,
Gilead Sciences,
Octagon Therapeutics,
Strm.bio,
Stellular Bio,
Sen-Jam Pharmaceutical,
Aleksia Therapeutics,
Fogarty International Center At Nih,
Acrivon Therapeutics, Inc..
Aldatu Biosciences's support email address is change@aldatubio.com
Aldatu Biosciences's categories are Biotechnology Research
Aldatu Biosciences's founding year is 2014
